Welcome back to the News section of Dispotech, your disposable excellence.
Today we will be talking about news published on dealstreetasia.com.
Microport Scientific Corp., a Shanghai-based medical device manufacturer, is considering expanding its business and offering its products for sale in Hong Kong; more specifically, the product presented on the market as their lead product, an artificial heart valve replacement.
The transcatheter aortic valve replacement is a minimally invasive procedure that involves installing an artificial valve without touching the existing one - which is malfunctioning.
The company in question could increase its profits by about $200 million by moving on the Hong Kong market, which today is one of the most interested in the world and definitely on the rise. Details and rumors about a possible offer are still being defined, according to the insiders.
An increasing number of medical and health care companies are planning a development strategy towards Hong Kong, due to the city’s permissive economic policies - especially when it comes to accommodating companies that deal in sectors such as biotechnology. An example of this is Pharma Inc., a biotech multinational that is collecting orders for an estimated amount of 457 million dollars; among other companies, the American Stealth BioTherapeutics Inc. and the Chinese Hua Medicine Ltd. have been among the first companies to “apply” for entry into this attractive and - recently - accessible part of the market.
Microport’s shares, which arrived in Hong Kong in 2010, have increased 42% over the past year, giving the company a market value of nearly $1.7 billion.
What do you think? Interested in finding out more? Contact Dispotech, your disposable excellence.